Navaneeth Narayanan, PharmD, MPH, BCIDP

Infectious Disease

Robert Wood Johnson University Hospital, New Brunswick, NJ

PharmD – Rutgers University, Ernest Mario School of Pharmacy, NJ
PGY-1 Pharmacy Practice Residency – Hunterdon Medical Center, Flemington, NJ
PGY-2 Infectious Disease Specialized Residency – University of California, San Francisco School of Pharmacy & Medical Center, San Francisco, CA
Global Health Clinical Scholars Program – University of California, San Francisco Global Health Sciences, San Francisco, CA
MPH (Epidemiology): Rutgers University School of Public Health, Piscataway, NJ

Board Certified Infectious Diseases Pharmacist (BCIDP, B11100816)
Immunization Certification (28RJ0456, NJ Board of Pharmacy)
Pharmacy-Based Immunization Delivery, American Pharmacists Association
Basic Life Support for Healthcare Providers, American Heart Association

Infectious diseases, antimicrobial resistance, tuberculosis, HIV, infections in immunocompromised hosts, clinical microbiology, antimicrobial susceptibility testing, antimicrobial stewardship & rapid microbiology diagnostics

Dr. Narayanan’s research program is focused on optimization of antimicrobial therapeutics and investigating the epidemiology of infectious diseases. There is a special emphasis on infectious diseases and global health threats includes drug-resistant bacterial infections, tuberculosis, COVID-19, HIV, infections in immunocompromised hosts, and vaccine hesitancy. The type of studies spans the research spectrum including observational epidemiological studies, comparative effectiveness research, translational research, pharmacokinetic studies, and clinical trials. Dr. Narayanan collaborates closely with basic science faculty and clinical researchers across Rutgers University and various other institutions.

Supported by a NIH/NIAID K23 Career Development Award (K23AI159396), Dr. Narayanan’s emerging independent research program seeks to integrate pharmacometrics and translational microbiome research (pharmacomicrobiomics), to develop precision medicine tools to optimize treatment response and outcomes for patients with tuberculosis.

Co-Chair, Breakpoint Working Group, Subcommittee on Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute (CLSI)
Advisor, Subcommittee on Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute (CLSI)

Adjunct Associate Professor, Division of Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School
Adjunct Faculty/TB Consultant, Rutgers Global Tuberculosis Institute, New Jersey Medical School
Faculty, Rutgers University Microbiome Program (RUMP)
Faculty, Center for Pharmaceutical Translational Research and Education (CEPTRE), Rutgers University Ernest Mario School of Pharmacy

Society of Scholars, New Jersey Alliance for Clinical and Translational Science (NJ ACTS) (2020)
Stuart D. Cook Excellence in Research Award, Rutgers School of Public Health (2019)
Leaders in Faculty Diversity Award, Rutgers University, Office of the Senior Vice President for Academic Affairs (2016)
Distinguished Service Award, Rutgers University Ernest Mario School of Pharmacy, Office for Student Development (2014)